| Artificial Intelligence Accelerates Industrial Innovation.. Rising as a Core Competitive Advantage also in the Medical Industry
| JNPMEDI Forms a New Organization to Maximize AI Capabilities... ‘Secured Holistic Growth for Innovation'
The medical industry is intensifying efforts to secure and enhance AI capabilities. Previously, AI was mainly used as an adjunct tool in medical fields such as interpreting results from imaging diagnostic devices like MRIs and CT scans. However, recent advancements in artificial intelligence technologies are rapidly positioning AI as a critical driver for securing competitive advantages in business.
Enhancing AI capabilities across various fields such as medical data platforms, dental medical devices, customized medical robots, and ultrasound diagnostics, the industry's movement to secure future growth momentum and technological hegemony is notable.
■ JNPMEDI Launches AI-Dedicated TF "Ensuring Sustainable Growth Momentum through R&D
JNPMEDI, a medical data platform company, has launched an AI Research and Development (R&D) Task Force under the supervision of the CTO to maximize AI capabilities and ensure sustainable growth momentum.
To maximize service quality across its digital medical business solutions by enhancing JNPMEDI's technological utilization, the AI R&D TF has been initiated, with a significant influx of specialized personnel in its data platform and development fields.
The newly structured TF is establishing and executing medium to long-term master plans for AI technology utilization. It aims to realize AI-based decision-making in various areas such as enhancing the efficiency of its self-developed Maven Clinical Cloud-based solutions, improving operational management capabilities to identify and mitigate risks in pharmaceutical and medical device commercialization processes, and establishing effective clinical data accumulation and analysis systems.
JNPMEDI anticipates that the new organization will significantly contribute to securing future growth momentum. It has also confirmed the deployment of an AI-dedicated team in numerous key projects. The TF is expected to play a pivotal role in designing automated processes during the ongoing development of AI cancer diagnosis solutions and clinical trial risk monitoring systems.
The new TF has also established various support systems to expand its influence. JNPMEDI plans to operate internal AI technology exchange sessions and seminars, led by a specialized research organization including product testers, software engineers, and clinical trial consultants. Additionally, it aims to actively support domestic and international conference participation to efficiently analyze the latest technological trends and application cases, thereby assisting in establishing directions and execution plans for AI adoption.
Meanwhile, leveraging its clinical operations and data management solution Maven Clinical Cloud, JNPMEDI operates a total digital medical business boosting solution. This provides on-demand services spanning all business stages from biopharmaceuticals and medical device product strategies to product development, clinical research, approvals, and technology transfer.
| Artificial Intelligence Accelerates Industrial Innovation.. Rising as a Core Competitive Advantage also in the Medical Industry
| JNPMEDI Forms a New Organization to Maximize AI Capabilities... ‘Secured Holistic Growth for Innovation'
The medical industry is intensifying efforts to secure and enhance AI capabilities. Previously, AI was mainly used as an adjunct tool in medical fields such as interpreting results from imaging diagnostic devices like MRIs and CT scans. However, recent advancements in artificial intelligence technologies are rapidly positioning AI as a critical driver for securing competitive advantages in business.
Enhancing AI capabilities across various fields such as medical data platforms, dental medical devices, customized medical robots, and ultrasound diagnostics, the industry's movement to secure future growth momentum and technological hegemony is notable.
■ JNPMEDI Launches AI-Dedicated TF "Ensuring Sustainable Growth Momentum through R&D
JNPMEDI, a medical data platform company, has launched an AI Research and Development (R&D) Task Force under the supervision of the CTO to maximize AI capabilities and ensure sustainable growth momentum.
To maximize service quality across its digital medical business solutions by enhancing JNPMEDI's technological utilization, the AI R&D TF has been initiated, with a significant influx of specialized personnel in its data platform and development fields.
The newly structured TF is establishing and executing medium to long-term master plans for AI technology utilization. It aims to realize AI-based decision-making in various areas such as enhancing the efficiency of its self-developed Maven Clinical Cloud-based solutions, improving operational management capabilities to identify and mitigate risks in pharmaceutical and medical device commercialization processes, and establishing effective clinical data accumulation and analysis systems.
JNPMEDI anticipates that the new organization will significantly contribute to securing future growth momentum. It has also confirmed the deployment of an AI-dedicated team in numerous key projects. The TF is expected to play a pivotal role in designing automated processes during the ongoing development of AI cancer diagnosis solutions and clinical trial risk monitoring systems.
The new TF has also established various support systems to expand its influence. JNPMEDI plans to operate internal AI technology exchange sessions and seminars, led by a specialized research organization including product testers, software engineers, and clinical trial consultants. Additionally, it aims to actively support domestic and international conference participation to efficiently analyze the latest technological trends and application cases, thereby assisting in establishing directions and execution plans for AI adoption.
Meanwhile, leveraging its clinical operations and data management solution Maven Clinical Cloud, JNPMEDI operates a total digital medical business boosting solution. This provides on-demand services spanning all business stages from biopharmaceuticals and medical device product strategies to product development, clinical research, approvals, and technology transfer.